Key result
Elevated exosomal miR-596 is linked to ~2.1-fold higher mortality in idiopathic pulmonary arterial hypertension.
Why the study?
Whether plasma exosomal microRNAs can predict survival in patients with idiopathic pulmonary arterial hypertension was uncertain.
Does plasma exosomal miR-596 level predict all-cause mortality in adult patients with idiopathic pulmonary arterial hypertension?
Cohort (n=58)
No
Does plasma exosomal miR-596 level predict all-cause mortality in adult patients with idiopathic pulmonary arterial hypertension?
Answers are grounded in this paper and cite their sources.
Plasma exosomal miR-596 serves as a novel, non-invasive independent biomarker strongly correlated with hemodynamic severity and survival in patients with idiopathic pulmonary arterial hypertension.
OBJECTIVE: To determine if plasma exosomal microRNAs (miRNAs) can predict survival in patients with idiopathic pulmonary arterial hypertension (IPAH). METHODS: The study enrolled patients with IPAH that underwent right heart catheterization. Plasma was collected and exosomal miRNAs were extracted. Exosomes were evaluated using transmission electron microscopy, Western blot analysis and particle size distribution analysis. MiRNAs were evaluated using a miRNA microarray and validated using real-time polymerase chain reaction. RESULTS: This study included 12 patients with IPAH in the study group and 48 patients with IPAH in the validation group. The mean ± SD follow-up duration was 60.3 ± 35.4 months in the overall cohort. The levels of miR-596 were higher in the nonsurvivors compared with the survivors. The levels of miR-596 significantly correlated with survival time, mean right atrial pressure, pulmonary vascular resistance (PVR) and cardiac index. High levels of miR-596 and PVR were significantly associated with poor overall survival. Multivariate analysis demonstrated that exosomal miR-596 (hazard ratio [HR] = 2.119; 95% confidence interval [CI] 1.402, 3.203) and PVR (HR = 1.146; 95% CI 1.010, 1.300) were independent predictors of survival. CONCLUSIONS: High levels of plasma exosomal miR-596 were significantly associated with disease severity and poor prognosis of patients with IPAH.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) conducted a cohort in Idiopathic pulmonary arterial hypertension (IPAH) (n=58). Plasma exosomal miR-596 levels vs. Lower plasma exosomal miR-596 levels (<2.6) or survivors was evaluated on All-cause mortality (overall survival) (HR 2.119, 95% CI 1.402-3.203, p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: